Clinical Study Results
What adverse reactions did the participants have?
The most common adverse reaction that happened during the study was redness
of the skin at the injection site.
The table below shows the adverse reactions that happened in at least 2 participants
during the study. There were other adverse reactions that happened during the study,
but those happened in fewer participants.
Most common adverse reactions during the study
50 mg 100 mg 200 mg 350 mg 500 mg
MEDI5884 MEDI5884 MEDI5884 MEDI5884 MEDI5884 Placebo
(out of 20 (out of 24 (out of 22 (out of 21 (out of 22 (out of 23
participants) participants) participants) participants) participants) participants)
Redness of the
skin at injection 0.0% (0) 4.2% (1) 13.6% (3) 19.0% (4) 0.0% (0) 8.7% (2)
site
Increase in
apolipoprotein
B, a protein
found in
5.0% (1) 4.2% (1) 0.0% (0) 4.8% (1) 0.0% (0) 4.3% (1)
cholesterol
(increases
risk of heart
disease)
Increase
in amount
triglycerides,
a type of fat,
5.0% (1) 0.0% (0) 0.0% (0) 0.0% (0) 4.5% (1) 0.0% (0)
in the blood
(increases
risk of heart
disease)
10